GGrantIndex
← Leaderboards

Ruth Halaban

Yale University

Google Scholar ↗PubMed ↗ORCID ↗
$8,123,059
Attributed
$10,456,424
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$33,875,539 · 14

By mechanism

P50$30,822,891 · 9
R01$1,211,683 · 1
P30$1,154,305 · 1
R21$678,660 · 2
R13$8,000 · 1

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Melanoma”

Research focus

MelanomaSkin CancerTumorMutationClinical TrialsBioinformaticsCellsMolecularResearch PersonnelMelanoma CellResourcesSpecimenCollaborationsGene ExpressionSkinResponseInhibitor/AntagonistProteomicsGeneticGenomicsBaseBiologicalFreezingBiostatistics Core

Grant awards (68)

Core B: Biospecimen Core$219,779
P50 · FY2025 · CA · contact PI
Core B: Biospecimen Core$209,255
P50 · FY2024 · CA · contact PI
Core B: Biospecimen Core$193,550
P50 · FY2023 · CA · contact PI
Core 2: Biospecimen Core$247,382
P50 · FY2022 · CA · contact PI
Core 2: Biospecimen Core$268,511
P50 · FY2021 · CA · contact PI
Core 2: Biospecimen Core$273,418
P50 · FY2020 · CA · contact PI
Core 2: Biospecimen Core$268,498
P50 · FY2019 · CA · contact PI
Core 2: Biospecimen Core$287,956
P50 · FY2018 · CA · contact PI
Integrative genomic biomarkers for predicting response to immunotherapy in melanoma patients$182,156
R21 · FY2018 · CA · contact PI
Yale SPORE in Skin Cancer$709,079
P50 · FY2017 · CA · contact PI
Integrative genomic biomarkers for predicting response to immunotherapy in melanoma patients$218,588
R21 · FY2017 · CA · contact PI
Specimen Resource Core$209,971
P50 · FY2017 · CA · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$156,681
P50 · FY2017 · CA
Molecular Diversity of Melanomas and Response to Targeted Therapy$25,000
P50 · FY2017 · CA · contact PI
Yale SPORE in Skin Cancer$25,000
P50 · FY2017 · CA · contact PI
Yale SPORE in Skin Cancer$2,161,999
P50 · FY2016 · CA · contact PI
Administration$184,681
P50 · FY2016 · CA · contact PI
Specimen Resource Core$157,899
P50 · FY2016 · CA · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$156,828
P50 · FY2016 · CA
Molecular Diversity of Melanomas and Response to Targeted Therapy$156,752
P50 · FY2016 · CA · contact PI
Yale SPORE in Skin Cancer$2,185,000
P50 · FY2015 · CA · contact PI
Administration$186,646
P50 · FY2015 · CA · contact PI
Specimen Resource Core$159,579
P50 · FY2015 · CA · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$158,496
P50 · FY2015 · CA
Molecular Diversity of Melanomas and Response to Targeted Therapy$158,420
P50 · FY2015 · CA · contact PI
Yale SPORE in Skin Cancer$2,154,341
P50 · FY2014 · CA · contact PI
Administration$183,592
P50 · FY2014 · CA · contact PI
Specimen Resource Core$156,968
P50 · FY2014 · CA · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$155,903
P50 · FY2014 · CA
Molecular Diversity of Melanomas and Response to Targeted Therapy$155,827
P50 · FY2014 · CA · contact PI
Yale SPORE in Skin Cancer$2,150,502
P50 · FY2013 · CA · contact PI
Administration$200,598
P50 · FY2013 · CA · contact PI
Specimen Resource Core$171,507
P50 · FY2013 · CA · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$170,344
P50 · FY2013 · CA
Molecular Diversity of Melanomas and Response to Targeted Therapy$170,261
P50 · FY2013 · CA · contact PI
Yale SPORE in Skin Cancer$2,300,000
P50 · FY2012 · CA · contact PI
Administration$195,640
P50 · FY2012 · CA · contact PI
Specimen Resource Core$167,269
P50 · FY2012 · CA · contact PI
The RAC1 Pathway as aTarget for Melanoma Therapy$166,133
P50 · FY2012 · CA
Molecular Diversity of Melanomas and Response to Targeted Therapy$166,052
P50 · FY2012 · CA · contact PI
Yale SPORE in Skin Cancer$500,000
P50 · FY2011 · CA · contact PI
Yale SPORE in Skin Cancer$2,233,298
P50 · FY2010 · CA · contact PI
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL$328,810
P50 · FY2010 · CA · contact PI
Yale SPORE in Skin Cancer$2,233,298
P50 · FY2009 · CA · contact PI
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL$328,810
P50 · FY2009 · CA · contact PI
Yale SPORE in Skin Cancer$2,233,298
P50 · FY2008 · CA · contact PI
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL$328,810
P50 · FY2008 · CA · contact PI
Cell Culture Core$225,798
P30 · FY2008 · AR · contact PI
Yale SPORE in Skin Cancer$2,233,300
P50 · FY2007 · CA · contact PI
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL$328,812
P50 · FY2007 · CA · contact PI
Cell Culture Core$174,034
P30 · FY2007 · AR · contact PI
Yale SPORE in Skin Cancer$2,300,000
P50 · FY2006 · CA · contact PI
SEROLOGICAL PROFILING OF MELANOMA PATIENTS AS A DIAGNOSTIC TOOL$180,387
P50 · FY2006 · CA · contact PI
Core C - Cell Culture Core$179,232
P30 · FY2006 · AR · contact PI
ADMINISTRATION CORE$168,751
P50 · FY2006 · CA · contact PI
Epigenetic Chromatin Changes as Melanoma Markers$137,306
R21 · FY2006 · CA · contact PI
Core C - Cell Culture Core$179,232
P30 · FY2005 · AR
Epigenetic Chromatin Changes as Melanoma Markers$140,610
R21 · FY2005 · CA
Core C - Cell Culture Core$179,232
P30 · FY2004 · AR
PROLIFERATION &MALIGNANT TRANSFORMATION OF MELANOCYTES$29,814
R01 · FY2004 · CA
2003 Conference Pan-American Society Pigment Cell Resea$8,000
R13 · FY2003 · AR
PROLIFERATION &MALIGNANT TRANSFORMATION OF MELANOCYTES$466,449
R01 · FY2002 · CA
CORE--CELL CULTURE$72,259
P30 · FY2002 · AR
PROLIFERATION &MALIGNANT TRANSFORMATION OF MELANOCYTES$270,436
R01 · FY2001 · CA
THERAPEUTIC TARGETS IN MELANOMAS$182,428
R01 · FY2001 · CA
CORE--CELL CULTURE$72,259
P30 · FY2001 · AR
PROLIFERATION &MALIGNANT TRANSFORMATION OF MELANOCYTES$262,556
R01 · FY2000 · CA
CORE--CELL CULTURE$72,259
P30 · FY2000 · AR